Analysis of the ADA's Standard of Diabetes Care Recommendation for Continuous Glucose Monitoring System. (November 2021)

• Record Type: Journal Article
• Authors: Zafra-Tanaka, Jessica Hanae; Brañez-Condorena, Ana; Soriano-Moreno, David R.; Taype-Rondan, Alvaro
• Is Part Of: Journal of diabetes science and technology. Volume 15:Number 6(2021)
• Page Start: 1390
• Page End: 1393
• Publication Date: 2021-11
• Subjects: hypoglycemia -- glycated hemoglobin A -- continuous glucose monitoring -- diabetes mellitus -- type 1; Diabetes -- Periodicals; Medical technology -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1177/1932296820952065
• Languages: English
• ISSNs: 1932-2968

Abstract

Transparency is a key factor to understand how recommendations were reached and to decide whether to adopt them or not. Currently, the American Diabetes Association (ADA) recommends the usage of real-time continuous glucose monitors in certain subgroups of people living with type 1 diabetes mellitus. In this commentary we sought to critically appraise this recommendation, mainly regarding the outcomes assessed, the evidence used for each outcome, and how the balance of benefits and harms was made. We found that the decision-making process followed to reach the ADA recommendation was not clear, and that the final recommendation does not seem to be supported in the assessed evidence.